Breaking News Instant updates and real-time market news.

ICFI

ICF International

$69.56 /

+1.14 (+1.67%)

17:23
11/05/20
11/05
17:23
11/05/20
17:23

ICF International reports Q3 non-GAAP EPS $1.10, consensus 87c

Reports Q3 revenue $360M, consensus $367.1M. CEO John Wasson said, "This was another quarter of strong performance for ICF, demonstrating the resilience of our diversified business model, excellent execution across our client set, and positive impact of our key growth catalysts. Service revenue increased 3% year-on-year, led by programs for federal government clients and energy-related advisory and implementation work for commercial clients. Favorable business mix, higher utilization and lower SG&A costs drove Adjusted EBITDA growth of 4.9% and resulted in a 14.3% Adjusted EBITDA margin on service revenue, 30 basis points above last year and 180 basis points ahead of the prior quarter. Another financial highlight of Q3 was operating cash flow, which increased by $84M, bringing year-to-date operating cash flow to $95 million, primarily due to improved collections. We utilized these funds to pay down $79M of long-term debt associated with the January acquisition of ITG. This was the highest third quarter for contract wins in the company's history, representing a trailing-12-month book-to-bill ratio of 1.2, setting the stage for future growth. ICF was awarded $792M in contracts, including strategic wins that align with the growth catalysts we have identified: IT modernization/digital transformation, public health, commercial energy and disaster management. In disaster management, we have won small but strategic mitigation contracts in four states since the beginning of this year and are awaiting award decisions on larger contracts in additional jurisdictions."

  • 05

    Nov

ICFI ICF International
$69.56 /

+1.14 (+1.67%)

07/01/20 Berenberg
ICF International upgraded to Buy from Hold at Berenberg
05/18/20 Canaccord
ICF International price target lowered to $80 from $88 at Canaccord
01/15/20 Barrington
ICF International price target raised to $104 from $98 at Barrington
12/19/19 Canaccord
ICF International initiated with a Buy at Canaccord

TODAY'S FREE FLY STORIES

Initiation
Atea Pharmaceuticals initiated with an Overweight at JPMorgan » 08:00
11/24/20
11/24
08:00
11/24/20
08:00
AVIR

Atea Pharmaceuticals

$33.39 /

+0.17 (+0.51%)

JPMorgan analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$33.39 /

+0.17 (+0.51%)

AVIR Atea Pharmaceuticals
$33.39 /

+0.17 (+0.51%)

06:59 Today William Blair
William Blair starts Atea Pharmaceuticals with Outperform, $60 fair value
06:17 Today William Blair
Atea Pharmaceuticals initiated with an Outperform at William Blair
  • 30
    Oct
Options
XPeng call buyer realizes 298% same-day gains » 08:00
11/24/20
11/24
08:00
11/24/20
08:00
XPEV

Xpeng

$72.22 /

+18.37 (+34.11%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV Xpeng
$72.22 /

+18.37 (+34.11%)

XPEV Xpeng
$72.22 /

+18.37 (+34.11%)

11/16/20 Citi
Xpeng price target raised to $57.71 from $34.70 at Citi
11/09/20 JPMorgan
Xpeng price target raised to $43 from $27 at JPMorgan
11/04/20
Fly Intel: Top five analyst initiations
11/04/20 Citi
Xpeng initiated with a Buy at Citi
XPEV Xpeng
$72.22 /

+18.37 (+34.11%)

  • 27
    Aug
XPEV Xpeng
$72.22 /

+18.37 (+34.11%)

XPEV Xpeng
$72.22 /

+18.37 (+34.11%)

Recommendations
Align Technology price target raised to $515 from $432 at Credit Suisse » 07:59
11/24/20
11/24
07:59
11/24/20
07:59
ALGN

Align Technology

$476.56 /

+30.13 (+6.75%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALGN Align Technology
$476.56 /

+30.13 (+6.75%)

ALGN Align Technology
$476.56 /

+30.13 (+6.75%)

07:07 Today Goldman Sachs
Align Technology price target raised to $535 from $472 at Goldman Sachs
06:55 Today Baird
Align Technology price target raised to $530 from $450 at Baird
06:26 Today Piper Sandler
Align Technology price target raised to $525 from $500 at Piper Sandler
11/23/20 Piper Sandler
Align Technology price target raised to $525 from $500 at Piper Sandler
ALGN Align Technology
$476.56 /

+30.13 (+6.75%)

ALGN Align Technology
$476.56 /

+30.13 (+6.75%)

ALGN Align Technology
$476.56 /

+30.13 (+6.75%)

Recommendations
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley » 07:58
11/24/20
11/24
07:58
11/24/20
07:58
KYMR

Kymera Therapeutics

$48.05 /

-1.55 (-3.13%)

, NRIX

Nurix Therapeutics

$37.43 /

-0.39 (-1.03%)

, CCCC

C4 Therapeutics

$29.07 /

+0.41 (+1.43%)

, ARVN

Arvinas

$23.34 /

+0.1 (+0.43%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$48.05 /

-1.55 (-3.13%)

NRIX Nurix Therapeutics
$37.43 /

-0.39 (-1.03%)

ARVN Arvinas
$23.34 /

+0.1 (+0.43%)

KYMR Kymera Therapeutics
$48.05 /

-1.55 (-3.13%)

11/13/20 Piper Sandler
Kymera Therapeutics initiated with an Overweight at Piper Sandler
09/15/20 Morgan Stanley
Kymera Therapeutics initiated with an Equal Weight at Morgan Stanley
09/15/20 Cowen
Cowen starts Kymera at Outperform, sees platform positioned for success
09/15/20 Guggenheim
Kymera Therapeutics initiated with a Buy at Guggenheim
NRIX Nurix Therapeutics
$37.43 /

-0.39 (-1.03%)

11/19/20 Baird
Baird starts Nurix Therapeutics with Outperform, $40 price target
11/18/20 Baird
Nurix Therapeutics initiated with an Outperform at Baird
08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
CCCC C4 Therapeutics
$29.07 /

+0.41 (+1.43%)

10/28/20 UBS
C4 Therapeutics initiated with a Buy at UBS
10/27/20 Jefferies
C4 Therapeutics initiated with a Buy at Jefferies
10/27/20 BMO Capital
C4 Therapeutics initiated with an Outperform at BMO Capital
ARVN Arvinas
$23.34 /

+0.1 (+0.43%)

10/14/20 Roth Capital
Pipeline expansion showcases Arvinas' PROTACs broad potential, says Roth Capital
06/01/20 Citi
Arvinas upgraded to Buy from Neutral at Citi
05/29/20 Roth Capital
Roth Capital recommends buying Arvinas on ASCO dip
05/29/20 Piper Sandler
Arvinas should be bought on weakness after ASCO update, says Piper Sandler
NRIX Nurix Therapeutics
$37.43 /

-0.39 (-1.03%)

ARVN Arvinas
$23.34 /

+0.1 (+0.43%)

  • 02
    Oct
  • 21
    Aug
  • 24
    Jul
Hot Stocks
Best Buy plans to resume share repurchases during Q4 » 07:57
11/24/20
11/24
07:57
11/24/20
07:57
BBY

Best Buy

$122.08 /

+2.9 (+2.43%)

The company suspended…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBY Best Buy
$122.08 /

+2.9 (+2.43%)

BBY Best Buy
$122.08 /

+2.9 (+2.43%)

10/29/20 R5 Capital
Best Buy upgraded to Hold from Sell at R5 Capital
10/28/20 Piper Sandler
Piper calls Best Buy a favorite idea after 'very favorable' checks
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
BBY Best Buy
$122.08 /

+2.9 (+2.43%)

BBY Best Buy
$122.08 /

+2.9 (+2.43%)

BBY Best Buy
$122.08 /

+2.9 (+2.43%)

BBY Best Buy
$122.08 /

+2.9 (+2.43%)

Recommendations
Chart Industries price target raised to $109 from $92 at Credit Suisse » 07:56
11/24/20
11/24
07:56
11/24/20
07:56
GTLS

Chart Industries

$103.77 /

+3.18 (+3.16%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTLS Chart Industries
$103.77 /

+3.18 (+3.16%)

GTLS Chart Industries
$103.77 /

+3.18 (+3.16%)

10/27/20 Citi
Chart Industries price target raised to $100 from $90 at Citi
10/23/20 Lake Street
Chart Industries price target raised to $111 from $81 at Lake Street
10/23/20 Craig-Hallum
Chart Industries price target raised to $107 from $85 at Craig-Hallum
10/23/20 Credit Suisse
Chart Industries price target raised to $92 from $80 at Credit Suisse
GTLS Chart Industries
$103.77 /

+3.18 (+3.16%)

Recommendations
Ambarella price target raised to $83 from $79 at Morgan Stanley » 07:52
11/24/20
11/24
07:52
11/24/20
07:52
AMBA

Ambarella

$66.20 /

-0.25 (-0.38%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$66.20 /

-0.25 (-0.38%)

AMBA Ambarella
$66.20 /

-0.25 (-0.38%)

06:55 Today Deutsche Bank
Ambarella price target raised to $60 from $50 at Deutsche Bank
06:49 Today Roth Capital
Ambarella price target raised to $70 from $55 at Roth Capital
11/23/20 Summit Insights
Ambarella upgraded to Buy from Hold at Summit Insights
11/04/20 KeyBanc
KeyBanc lays out possible M&A candidates as semi consolidation heats ups
AMBA Ambarella
$66.20 /

-0.25 (-0.38%)

AMBA Ambarella
$66.20 /

-0.25 (-0.38%)

AMBA Ambarella
$66.20 /

-0.25 (-0.38%)

Recommendations
Nutanix price target raised to $35 from $27 at Wells Fargo » 07:47
11/24/20
11/24
07:47
11/24/20
07:47
NTNX

Nutanix

$28.42 /

-0.07 (-0.25%)

Wells Fargo analyst Aaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

07:40 Today Northland
Nutanix price target raised to $38 from $31 at Northland
07:18 Today RBC Capital
Nutanix price target raised to $34 from $29 at RBC Capital
06:28 Today Piper Sandler
Nutanix price target raised to $30 from $26 at Piper Sandler
05:18 Today Goldman Sachs
Nutanix upgraded to Neutral from Sell at Goldman Sachs
NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

Hot Stocks
Goldfield to be acquired by First Reserve for $7.00 per share » 07:46
11/24/20
11/24
07:46
11/24/20
07:46
GV

Goldfield Corp

$4.25 /

-0.02 (-0.47%)

The Goldfield Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
GV Goldfield Corp
$4.25 /

-0.02 (-0.47%)

Recommendations
Agilent price target raised to $120 from $105 at Wells Fargo » 07:46
11/24/20
11/24
07:46
11/24/20
07:46
A

Agilent

$112.18 /

+1.28 (+1.15%)

Wells Fargo analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
A Agilent
$112.18 /

+1.28 (+1.15%)

A Agilent
$112.18 /

+1.28 (+1.15%)

06:52 Today Baird
Agilent price target raised to $118 from $104 at Baird
06:30 Today Citi
Agilent price target raised to $115 from $100 at Citi
11/17/20 Cleveland Research
Agilent upgraded to Buy from Neutral at Cleveland Research
11/09/20 KeyBanc
Agilent initiated with an Overweight at KeyBanc
A Agilent
$112.18 /

+1.28 (+1.15%)

A Agilent
$112.18 /

+1.28 (+1.15%)

A Agilent
$112.18 /

+1.28 (+1.15%)

Syndicate
SmileDirectClub 10M share Block Trade priced at $11.75 » 07:45
11/24/20
11/24
07:45
11/24/20
07:45
SDC

SmileDirectClub

$12.46 /

+1.57 (+14.42%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

09/17/20 Stifel
SmileDirectClub price target raised to $14 from $11 at Stifel
09/09/20 Wolfe Research
Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off
09/09/20 Wolfe Research
SmileDirectClub upgraded to Peer Perform from Underperform at Wolfe Research
09/03/20 Stifel
SmileDirectClub imminent price increase can create 'solid' tailwind, says Stifel
SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

SDC SmileDirectClub
$12.46 /

+1.57 (+14.42%)

General news
Treasury Market Outlook: stocks extended gains overnight » 07:45
11/24/20
11/24
07:45
11/24/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Jefferies downgrades Ulta Beauty to Hold after holiday spending survey » 07:43
11/24/20
11/24
07:43
11/24/20
07:43
ULTA

Ulta Beauty

$282.71 /

+8.93 (+3.26%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

05:30 Today Jefferies
Ulta Beauty downgraded to Hold from Buy at Jefferies
11/23/20 Oppenheimer
Ulta Beauty price target raised to $305 from $280 at Oppenheimer
11/18/20 R5 Capital
Target upgraded to Buy at R5 Capital following quarterly results
11/18/20 Piper Sandler
Ulta Beauty price target raised to $300 from $288 at Piper Sandler
ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

ULTA Ulta Beauty
$282.71 /

+8.93 (+3.26%)

Hot Stocks
iBio issued U.S. patent covering endostatin peptides for treating fibrosis » 07:41
11/24/20
11/24
07:41
11/24/20
07:41
IBIO

iBio

$1.47 /

-0.13 (-8.13%)

iBio announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBIO iBio
$1.47 /

-0.13 (-8.13%)

IBIO iBio
$1.47 /

-0.13 (-8.13%)

11/18/20 Alliance Global Partners
iBio price target lowered to $2 from $3.10 at Alliance Global Partners
08/11/20 Alliance Global Partners
iBio price target raised to $6.65 from $2.55 at Alliance Global Partners
06/26/20 Alliance Global Partners
iBio initiated with a Buy at Alliance Global Partners
IBIO iBio
$1.47 /

-0.13 (-8.13%)

IBIO iBio
$1.47 /

-0.13 (-8.13%)

IBIO iBio
$1.47 /

-0.13 (-8.13%)

Hot Stocks
Capricor Therapeutics starts dosing patients in Phase 2 trial of CAP-1002 » 07:40
11/24/20
11/24
07:40
11/24/20
07:40
CAPR

Capricor Therapeutics

$4.17 /

-0.16 (-3.70%)

Capricor Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CAPR Capricor Therapeutics
$4.17 /

-0.16 (-3.70%)

CAPR Capricor Therapeutics
$4.17 /

-0.16 (-3.70%)

02/03/20 Maxim
Capricor Therapeutics upgraded to Buy from Hold at Maxim
CAPR Capricor Therapeutics
$4.17 /

-0.16 (-3.70%)

CAPR Capricor Therapeutics
$4.17 /

-0.16 (-3.70%)

Recommendations
Nutanix price target raised to $38 from $31 at Northland » 07:40
11/24/20
11/24
07:40
11/24/20
07:40
NTNX

Nutanix

$28.42 /

-0.07 (-0.25%)

Northland analyst Nehal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

07:18 Today RBC Capital
Nutanix price target raised to $34 from $29 at RBC Capital
06:28 Today Piper Sandler
Nutanix price target raised to $30 from $26 at Piper Sandler
05:18 Today Goldman Sachs
Nutanix upgraded to Neutral from Sell at Goldman Sachs
11/19/20 OTR Global
Nutanix upgraded to Positive from Mixed at OTR Global
NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

NTNX Nutanix
$28.42 /

-0.07 (-0.25%)

Earnings
Anaplan raises FY21 revenue view to $444M-$445M, consensus $438.63M » 07:39
11/24/20
11/24
07:39
11/24/20
07:39
PLAN

Anaplan

$62.26 /

+0.12 (+0.19%)

Prior FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

11/19/20 RBC Capital
Anaplan quarter 'bit too close to call,' says RBC Capital
11/18/20 Mizuho
Anaplan well positioned to exceed Q3 estimates, says Mizuho
11/12/20 Deutsche Bank
Anaplan price target raised to $75 from $70 at Deutsche Bank
11/10/20
Fly Intel: Top five analyst initiations
PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

Upgrade
Target upgraded to Buy from Hold at Argus » 07:38
11/24/20
11/24
07:38
11/24/20
07:38
TGT

Target

$177.70 /

+5.38 (+3.12%)

, WMT

Walmart

$150.97 /

+0.73 (+0.49%)

Argus analyst Christopher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$177.70 /

+5.38 (+3.12%)

WMT Walmart
$150.97 /

+0.73 (+0.49%)

TGT Target
$177.70 /

+5.38 (+3.12%)

07:24 Today Argus
Target upgraded to Buy from Hold at Argus
11/19/20 DA Davidson
Target price target raised to $208 from $179 at DA Davidson
11/19/20 MKM Partners
Target upgraded to Neutral from Sell at MKM Partners
11/19/20 Morgan Stanley
Target price target raised to $180 from $165 at Morgan Stanley
WMT Walmart
$150.97 /

+0.73 (+0.49%)

11/18/20 Raymond James
Walmart price target raised to $165 from $145 at Raymond James
11/18/20 DA Davidson
Walmart price target raised to $177 from $154 at DA Davidson
11/18/20 BMO Capital
Walmart price target raised to $175 from $160 at BMO Capital
11/18/20 MKM Partners
Walmart price target raised to $154 from $147 at MKM Partners
TGT Target
$177.70 /

+5.38 (+3.12%)

WMT Walmart
$150.97 /

+0.73 (+0.49%)

TGT Target
$177.70 /

+5.38 (+3.12%)

WMT Walmart
$150.97 /

+0.73 (+0.49%)

TGT Target
$177.70 /

+5.38 (+3.12%)

WMT Walmart
$150.97 /

+0.73 (+0.49%)

TGT Target
$177.70 /

+5.38 (+3.12%)

WMT Walmart
$150.97 /

+0.73 (+0.49%)

Hot Stocks
Dick's Sporting President says stores drove 90% of total Q3 sales growth » 07:38
11/24/20
11/24
07:38
11/24/20
07:38
DKS

Dick's Sporting

$58.80 /

+0.29 (+0.50%)

Lauren Hobart, President,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

11/10/20 Cowen
Dick's Sporting weakness a buying opportunity, says Cowen
09/25/20 Cleveland Research
Dick's Sporting upgraded to Buy from Neutral at Cleveland Research
08/27/20
Fly Intel: Top five analyst downgrades
08/27/20
Fly Intel: Top five analyst upgrades
DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

Initiation
Electromed initiated with an Outperform at Northland » 07:37
11/24/20
11/24
07:37
11/24/20
07:37
ELMD

Electromed

$9.53 /

-0.195 (-2.01%)

Northland analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELMD Electromed
$9.53 /

-0.195 (-2.01%)

Recommendations
Altra Industrial Motion price target raised to $62 from $52 at Oppenheimer » 07:37
11/24/20
11/24
07:37
11/24/20
07:37
AIMC

Altra Industrial Motion

$54.59 /

+0.73 (+1.36%)

Oppenheimer analyst Bryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIMC Altra Industrial Motion
$54.59 /

+0.73 (+1.36%)

AIMC Altra Industrial Motion
$54.59 /

+0.73 (+1.36%)

11/18/20 KeyBanc
Altra Industrial Motion price target raised to $65 from $50 at KeyBanc
10/26/20 Rosenblatt
Altra Industrial Motion price target raised to $50 from $42 at Rosenblatt
10/26/20 Oppenheimer
Altra Industrial Motion price target raised to $52 from $46 at Oppenheimer
10/26/20 BMO Capital
Altra Industrial Motion price target raised to $55 from $45 at BMO Capital
AIMC Altra Industrial Motion
$54.59 /

+0.73 (+1.36%)

Hot Stocks
Strongbridge announces publication of data from Phase 3 SONICS study of RECORLEV » 07:36
11/24/20
11/24
07:36
11/24/20
07:36
SBBP

Strongbridge Biopharma

$2.71 /

+0.02 (+0.74%)

Strongbridge Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$2.71 /

+0.02 (+0.74%)

SBBP Strongbridge Biopharma
$2.71 /

+0.02 (+0.74%)

09/08/20 JMP Securities
Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities
03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
SBBP Strongbridge Biopharma
$2.71 /

+0.02 (+0.74%)

  • 17
    Sep
SBBP Strongbridge Biopharma
$2.71 /

+0.02 (+0.74%)

Earnings
Anaplan sees Q4 revenue $118.5M-$119.5 , consensus $118.42M » 07:36
11/24/20
11/24
07:36
11/24/20
07:36
PLAN

Anaplan

$62.26 /

+0.12 (+0.19%)

Sees Q4 Non-GAAP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

11/19/20 RBC Capital
Anaplan quarter 'bit too close to call,' says RBC Capital
11/18/20 Mizuho
Anaplan well positioned to exceed Q3 estimates, says Mizuho
11/12/20 Deutsche Bank
Anaplan price target raised to $75 from $70 at Deutsche Bank
11/10/20
Fly Intel: Top five analyst initiations
PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

PLAN Anaplan
$62.26 /

+0.12 (+0.19%)

Upgrade
Cleveland-Cliffs upgraded to Buy from Hold at GLJ Research » 07:36
11/24/20
11/24
07:36
11/24/20
07:36
CLF

Cleveland-Cliffs

$9.94 /

+0.715 (+7.75%)

, X

U.S. Steel

$11.57 /

+0.605 (+5.52%)

GLJ Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

X U.S. Steel
$11.57 /

+0.605 (+5.52%)

CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

07:34 Today GLJ Research
U.S. Steel upgraded to Buy from Hold at GLJ Research
11/20/20 KeyBanc
Cleveland-Cliffs upgraded to Overweight from Sector Weight at KeyBanc
11/20/20 KeyBanc
Cleveland-Cliffs upgraded to Overweight from Sector Weight at KeyBanc
10/26/20 B. Riley Securities
Cleveland-Cliffs price target raised to $13 from $10 at B. Riley Securities
X U.S. Steel
$11.57 /

+0.605 (+5.52%)

07:34 Today GLJ Research
U.S. Steel upgraded to Buy from Hold at GLJ Research
09/17/20 GLJ Research
U.S. Steel price target lowered to $7.36 from $13 at GLJ Research
06/09/20 GLJ Research
U.S. Steel upgraded to Hold from Sell at GLJ Research
03/23/20 BMO Capital
U.S. Steel price target lowered to $6 from $9 at BMO Capital
CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

X U.S. Steel
$11.57 /

+0.605 (+5.52%)

  • 18
    Jun
CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

X U.S. Steel
$11.57 /

+0.605 (+5.52%)

CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

X U.S. Steel
$11.57 /

+0.605 (+5.52%)

CLF Cleveland-Cliffs
$9.94 /

+0.715 (+7.75%)

X U.S. Steel
$11.57 /

+0.605 (+5.52%)

Earnings
Dick's Sporting not providing an updated FY20 outlook at this time » 07:36
11/24/20
11/24
07:36
11/24/20
07:36
DKS

Dick's Sporting

$58.80 /

+0.29 (+0.50%)

As previously announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

11/10/20 Cowen
Dick's Sporting weakness a buying opportunity, says Cowen
09/25/20 Cleveland Research
Dick's Sporting upgraded to Buy from Neutral at Cleveland Research
08/27/20
Fly Intel: Top five analyst downgrades
08/27/20
Fly Intel: Top five analyst upgrades
DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

DKS Dick's Sporting
$58.80 /

+0.29 (+0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.